Top Story

Surgery remains ‘gold standard’ for basal cell carcinoma

September 1, 2014

Surgery remains the ideal treatment for patients with basal cell carcinoma, according to results of an evidence review.

Researchers with Columbia University Medical Center’s department of dermatology searched four databases — PubMed, Ovid MEDLINE, Cochrane Central Register of Controlled Trials and Cochrane Database of Systemic Reviews — to identify randomized controlled trials, systematic reviews or comparative studies that focused on treatment for basal cell carcinoma (BCC).

FDA News

FDA lifts clinical hold on vantictumab for NSCLC, breast cancer, pancreatic cancer

August 31, 2014
OncoMed Pharmaceuticals recently announced that the FDA has removed the partial clinical hold on enrollment in phase 1 clinical trials for the company’s monoclonal…
Industry News

Growth estimated in B-cell NHL treatment market value

August 30, 2014
The market value of B-cell non-Hodgkin’s lymphoma treatments will experience moderate growth across six major markets from $4.59 billion in 2013 to $5.41 billion…
In the Journals

S-1 noninferior to UFT/LV for stage III colon cancer

August 29, 2014
Adjuvant chemotherapy with the oral fluoropyrimidine derivative S-1 conferred similar DFS rates as tegafur-uracil plus leucovorin among patients with stage III
More News Headlines »
CME CNE

Treatment Decision-Making through the Spectrum of MDS: Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

8/20/2014
MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
figure

Docetaxel plus ADT improved OS in metastatic prostate cancer

June 24, 2014
CHICAGO — Donald L. Trump, MD, FACP, president and CEO at Roswell Park Cancer Institute and HemOnc Today
More »
CME

Applying Imaging, Biomarkers, and Immunotherapy in the Management of NSCLC

This activity is supported by an educational grant from Genentech, Inc.

8/7/2014
Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, but the numerous subtypes make this disease…
More »